Preparation and Biological Properties of HA Containing Astragalus Polysaccharides

doi:10.3724/SP.J.1077.2011.00022

Abstract

Abstract: Hydroxyapatite (HA) powders containing differentconcentrations of astragalus polysaccharides (APS) were synthesized by a wetchemical method. The effect of APS on the crystal structure, crystallinity andcrystal size of HA was characterized by XRD, the crystal morphologies of HA and HA/APS were characterized by TEM, the particle sizeand specific surface area of HA were detected by laser partical size distributionanalyzer, automated surface area and pore size analyzer, respectively. Furthermore,the effective concentration of APS on MC3T3-E1 osteoblasts, HA/APS onosteoblastic activity and differentiation was evaluated by Alamar blue, MTT andalkaline phosphatase assay. Cell morphologe was observed by light microscope.The results showed that the crystal structure, crystallinity andcrystal size of HA were not obviously effected by the presence of APS. Crystal morphologies of HA/APS was almost the samecompared with HA, the average particle size of HA was 1.17 μm and specificsurface area was 132.194 m²/g. The effect of APS on osteoblasts wastime and dose-dependent, APS concentrations within 80-200 μg/mL enhanced osteoblastic activity and ALPexpression, HA/APS enhanced osteoblastic activity and the osteoblasts hadintegrated morphology. It can be concluded that 0.5 g of HA containing 100-250 μm APS can promote osteoblastic activity. HA/APShas the promising potential as bone defect filling material for clinical applications.

Key words: hydroxyapatite, astragaluspolysaccharides, biological properties

CLC Number:

TB321

CHANG Li-Na,QU Shu-Xin, LIN Sun-Zhong, DUAN Ke, WENGJie. Preparation and Biological Properties of HA Containing Astragalus Polysaccharides[J]. Journal of Inorganic Materials, 2011, 26(1): 22-28.

References

[1] Dorozhkin S V. Calcium orthophosphates in nature, biology andmedicine. Materials, 2009, 2: 399-498.
[2] Itokazu M, Yang W, Aoki T, etal. Synthesis of antibiotic-loaded interporous hydroxyapatite blocks byvacuum method and <>in vitro drug release testing. Biomaterials, 1998, 19(7/8/9):817-819.
[3] Kilian O, Fuhrmann R, Alt V, etal. Plasma transglutaminase factor XIII induces microvessel ingrowth intobiodegradable hydroxyapatite implants in rats. Biomaterials, 2005, 26(14):1819-1827.
[4] Wu J B, Fong Y C,Tsai H Y, et al. Naringin-induced bone morphogenetic protein-2 expression <>via PI3K,Akt, c-Fos/c-Jun and AP-1 pathway in osteoblasts. Eur. J. Pharmacol., 2008, 588(2/3): 333-341.
[5] Lin F H, Guo C D,Chen K S, et al.Immobilization of chineseherbal medicine onto the surface-modiﬁed calcium hydrogenph- osphate. Biomaterials, 2003, 24(13): 2413-2422.
[6] 任鹏宇, 刘娟, 刘彦宁, 等. 丹红注射液-磷酸钙骨水泥释放体系的力学性能、显微结构及体外释放. 中国组织工程研究与临床康复, 2009, 13(3): 487-792.
[7] 黄相杰,姜红江, 刘德忠, 等. 磷酸钙骨水泥/丹参缓释系统植入治疗股骨头缺血性坏死. 中国修复重建外科杂志, 2008, 22(3): 307-310.
[8] 李茂红, 屈树新, 姚宁, 等(LI Mao-Hong,et al). 载不同浓度香丹注射液磷酸钙骨水泥性能研究. 无机材料学报(Journal of InorganicMaterials), 2010, 25(5): 507-511.
[9] 屈树新, 翁杰, 沈如, 等. 含中药的磷酸钙生物材料制备方法的研究. 生物医学工程与临床,2005, 9(2): 65-68.
[10]许春姣, 翦新春, 郭峰, 等. 黄芪多糖对犬骨髓基质干细胞增殖及超微结构的影响. 华西口腔医学杂志, 2007, 25(5): 432-436.
[11] 张宇明, 卫小春. 兔关节软骨细胞体外培养的生物学特性及中药黄芪对其的影响. 中国骨伤, 2005, 18(5): 275-277.
[12]Balasundarama G, Satoa M,Webster T J. Using hydroxyapatite nanoparticles and decreased crystallinity to promoteosteoblast adhesion similar to functionalizing with RGD. Biomaterials, 2006, 27(14): 2798-2805.
[13]祁景玉. X射线结构分析. 上海: 同济大学出版社, 2003: 72-75.
[14] Pang Y X, Bao X. Influenceof temperature, ripening time and calcination on the morphology andcrystallinity of hydroxyapatite nanoparticles. J. Eur. Ceram. Soc., 2003 (23): 1697-1704.
[15] 邱桂香, 孟昭慧, 冯长德. 关于中药粉灭菌方法的探讨. 黑龙江医药. 1995, 8(3): 149-150.
[16] 郁帅陆, 何旬, 陆利霞, 等. 黄芪固态发酵中有效成分的变化. 食品与药品. 2007, 9(3):8-10.
[17]Liu YR, Qu S X , Maitz M F, et al. The effect of the major components of Salvia MiltiorrhizaBunge on bone marrow cells. J. Ethnopharmacol.,2007, 111(3): 573-583.
[18]Yu HY, VandeVord P J, Mao L, et al. Improvedtissue-engineered bone regeneration by endothelial cell mediated vascularization. Biomaterials, 2009, 30(4): 508-517.
[19]CiapettiG, Ambrosio L, Savarino L,et al. Osteoblast growth and function in porouspoly e-caprolactone matrices for bone repair: a preliminary study. Biomaterials, 2003, 24(21): 3815-3824.
[20]MatsumotoT, Okazaki M, Inoue M, et al. Crystallinity and solubilitycharacteristics of hydroxyapatite adsorbed amino acid. <>Biomaterials, 2002,23(10): 2241-2247.
[21]BoonsongritY, Abe H, Sato K, et al. Controlledrelease of bovine serum albumin from hydroxyapatite microspheres for proteindelivery system. Mater. Sci. Eng. B,2008, 148(1/2/3): 162-165.
[22]王拥军, 宋莉君, 孙爱贞, 等. 黄芪多糖的提取及对体外培养成骨细胞成骨能力的影响. 中国中医骨伤科杂志, 1999, 7(6): 1-4.
[23] Shao B M, Xu W, Dai H,et al. A study on the immune receptors for polysaccharides from the roots of astragalusmembranaceus, a chinese medicinal herb. Biochem.Biophys. Res. Commun., 2004, 320(4): 1103-1111.
[24]Yuasa T, Miyamoto Y, Ishikawab K,et al. Effects of apatite cementson proliferation and differentiation of human osteoblasts in vitro. Biomaterials, 2004, 25(7/8): 1159-1166.